Si-Bone (SIBN) Cash from Investing Activities Growth (3y) (2020 - 2026)
Si-Bone (SIBN) Cash from Investing Activities Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 17.83% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -6.23% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -24.52% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -32.54% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -68.12% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 37.39% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -11.04% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 19.58% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -17.67% |
| 10 | Si-Bone | 887.32 Mn | 741.38 Mn | 44.55 Mn | -47.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -47.37% |
| Mar 31, 2026 | -36.31% |
| Dec 31, 2025 | 427.00% |
| Sep 30, 2025 | -46.57% |
| Jun 30, 2025 | -41.99% |
| Mar 31, 2025 | 35.18% |
| Dec 31, 2024 | -34.42% |
| Sep 30, 2024 | -47.97% |
| Jun 30, 2024 | -28.27% |
| Mar 31, 2024 | 42.46% |
| Dec 31, 2023 | 34.67% |
| Sep 30, 2023 | -119.94% |
| Jun 30, 2023 | -30.25% |
| Mar 31, 2023 | 51.90% |
| Dec 31, 2022 | -74.82% |
| Sep 30, 2022 | 4.15% |
| Jun 30, 2022 | 24.10% |
| Mar 31, 2022 | -59.68% |
| Dec 31, 2021 | 29.24% |
| Sep 30, 2021 | 656.83% |